Clinical

Short Takes

Publish date: December 29, 2017

 

Early furosemide treatment associated with decrease in hospital mortality for acute heart failure

This prospective multicenter observational trial showed that if intravenous furosemide was administered to patients with acute heart failure who had prominent congestive symptoms within 60 minutes of their arrival to the emergency department, it was associated with a decrease in hospital mortality (odds ratio, 0.42; 95% confidence interval, 0.24-0.72; P less than.001) even after the researchers adjusted for Get With The Guidelines heart failure risk scores.

Citation: Matsue Y et al. Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol. 2017 Jun 27;69(25):3042-51.

Recommended Reading

Observing BP measurement made no difference in SPRINT
The Hospitalist
Benefit of dabigatran over warfarin persists in AF patient subgroups undergoing PCI
The Hospitalist
Pharmacomechanical thrombolysis does not reduce post-thrombotic syndrome risk
The Hospitalist
Underlying peripheral arterial or venous disease in patients with lower extremity SSTIs
The Hospitalist
Acute kidney injury linked with doubled inpatient VTEs
The Hospitalist
Outcomes of alcohol septal ablation in younger patients with obstructive hypertrophic cardiomyopathy
The Hospitalist
Use of the dual-antiplatelet therapy score to guide treatment duration after percutaneous coronary intervention
The Hospitalist
Journal of Hospital Medicine – Dec. 2017
The Hospitalist
FDA approves angiotensin II for shock patients
The Hospitalist
ACC guidance addresses newer HFrEF options
The Hospitalist
   Comments ()